178 related articles for article (PubMed ID: 19265040)
41. Cardiac Fibroblast-Specific Activating Transcription Factor 3 Protects Against Heart Failure by Suppressing MAP2K3-p38 Signaling.
Li Y; Li Z; Zhang C; Li P; Wu Y; Wang C; Bond Lau W; Ma XL; Du J
Circulation; 2017 May; 135(21):2041-2057. PubMed ID: 28249877
[TBL] [Abstract][Full Text] [Related]
42. ASK1 regulates cardiomyocyte death but not hypertrophy in transgenic mice.
Liu Q; Sargent MA; York AJ; Molkentin JD
Circ Res; 2009 Nov; 105(11):1110-7. PubMed ID: 19815822
[TBL] [Abstract][Full Text] [Related]
43. Enhanced Galphaq signaling: a common pathway mediates cardiac hypertrophy and apoptotic heart failure.
Adams JW; Sakata Y; Davis MG; Sah VP; Wang Y; Liggett SB; Chien KR; Brown JH; Dorn GW
Proc Natl Acad Sci U S A; 1998 Aug; 95(17):10140-5. PubMed ID: 9707614
[TBL] [Abstract][Full Text] [Related]
44. MicroRNA-350 induces pathological heart hypertrophy by repressing both p38 and JNK pathways.
Ge Y; Pan S; Guan D; Yin H; Fan Y; Liu J; Zhang S; Zhang H; Feng L; Wang Y; Xu R; Yin JQ
Biochim Biophys Acta; 2013 Jan; 1832(1):1-10. PubMed ID: 23000971
[TBL] [Abstract][Full Text] [Related]
45. Acute heart failure with cardiomyocyte atrophy induced in adult mice by ablation of cardiac myosin light chain kinase.
Massengill MT; Ashraf HM; Chowdhury RR; Chrzanowski SM; Kar J; Warren SA; Walter GA; Zeng H; Kang BH; Anderson RH; Moss RL; Kasahara H
Cardiovasc Res; 2016 Jul; 111(1):34-43. PubMed ID: 27025239
[TBL] [Abstract][Full Text] [Related]
46. Regulator of G Protein Signaling 6 Facilities Cardiac Hypertrophy by Activating Apoptosis Signal-Regulating Kinase 1-P38/c-JUN N-Terminal Kinase 1/2 Signaling.
Huang Z; Shu J; Jiang W; Jiang M; Lu Y; Dai H; Xu N; Yuan H; Cai J
J Am Heart Assoc; 2018 Oct; 7(19):e009179. PubMed ID: 30371330
[TBL] [Abstract][Full Text] [Related]
47. Adiponectin deficiency exacerbates cardiac dysfunction following pressure overload through disruption of an AMPK-dependent angiogenic response.
Shimano M; Ouchi N; Shibata R; Ohashi K; Pimentel DR; Murohara T; Walsh K
J Mol Cell Cardiol; 2010 Aug; 49(2):210-20. PubMed ID: 20206634
[TBL] [Abstract][Full Text] [Related]
48. Growth/differentiation factor 1 alleviates pressure overload-induced cardiac hypertrophy and dysfunction.
Zhang Y; Zhang XF; Gao L; Liu Y; Jiang DS; Chen K; Yang Q; Fan GC; Zhang XD; Huang C
Biochim Biophys Acta; 2014 Feb; 1842(2):232-44. PubMed ID: 24275554
[TBL] [Abstract][Full Text] [Related]
49. Raf-1 kinase is required for cardiac hypertrophy and cardiomyocyte survival in response to pressure overload.
Harris IS; Zhang S; Treskov I; Kovacs A; Weinheimer C; Muslin AJ
Circulation; 2004 Aug; 110(6):718-23. PubMed ID: 15289381
[TBL] [Abstract][Full Text] [Related]
50. Diacylglycerol kinase-epsilon restores cardiac dysfunction under chronic pressure overload: a new specific regulator of Galpha(q) signaling cascade.
Niizeki T; Takeishi Y; Kitahara T; Arimoto T; Ishino M; Bilim O; Suzuki S; Sasaki T; Nakajima O; Walsh RA; Goto K; Kubota I
Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H245-55. PubMed ID: 18487437
[TBL] [Abstract][Full Text] [Related]
51. ROCK1 plays an essential role in the transition from cardiac hypertrophy to failure in mice.
Shi J; Zhang YW; Yang Y; Zhang L; Wei L
J Mol Cell Cardiol; 2010 Nov; 49(5):819-28. PubMed ID: 20709073
[TBL] [Abstract][Full Text] [Related]
52. HDAC6 contributes to pathological responses of heart and skeletal muscle to chronic angiotensin-II signaling.
Demos-Davies KM; Ferguson BS; Cavasin MA; Mahaffey JH; Williams SM; Spiltoir JI; Schuetze KB; Horn TR; Chen B; Ferrara C; Scellini B; Piroddi N; Tesi C; Poggesi C; Jeong MY; McKinsey TA
Am J Physiol Heart Circ Physiol; 2014 Jul; 307(2):H252-8. PubMed ID: 24858848
[TBL] [Abstract][Full Text] [Related]
53. Tetrandrine blocks cardiac hypertrophy by disrupting reactive oxygen species-dependent ERK1/2 signalling.
Shen DF; Tang QZ; Yan L; Zhang Y; Zhu LH; Wang L; Liu C; Bian ZY; Li H
Br J Pharmacol; 2010 Feb; 159(4):970-81. PubMed ID: 20105174
[TBL] [Abstract][Full Text] [Related]
54. MKK4 activates non-canonical NFκB signaling by promoting NFκB2-p100 processing.
Kim JS; Kim EJ; Kim HS; Kurie JM; Ahn YH
Biochem Biophys Res Commun; 2017 Sep; 491(2):337-342. PubMed ID: 28733031
[TBL] [Abstract][Full Text] [Related]
55. C1q-tumour necrosis factor-related protein-3 exacerbates cardiac hypertrophy in mice.
Ma ZG; Yuan YP; Zhang X; Xu SC; Kong CY; Song P; Li N; Tang QZ
Cardiovasc Res; 2019 May; 115(6):1067-1077. PubMed ID: 30407523
[TBL] [Abstract][Full Text] [Related]
56. Targeted disruption of Hspa4 gene leads to cardiac hypertrophy and fibrosis.
Mohamed BA; Barakat AZ; Zimmermann WH; Bittner RE; Mühlfeld C; Hünlich M; Engel W; Maier LS; Adham IM
J Mol Cell Cardiol; 2012 Oct; 53(4):459-68. PubMed ID: 22884543
[TBL] [Abstract][Full Text] [Related]
57. Transgenic mice with cardiac-specific over-expression of MLK7 have increased mortality when exposed to chronic beta-adrenergic stimulation.
Christe M; Jin N; Wang X; Gould KE; Iversen PW; Yu X; Lorenz JN; Kadambi V; Zuckerman SH; Bloem LJ
J Mol Cell Cardiol; 2004 Sep; 37(3):705-15. PubMed ID: 15350844
[TBL] [Abstract][Full Text] [Related]
58. Talin1 has unique expression versus talin 2 in the heart and modifies the hypertrophic response to pressure overload.
Manso AM; Li R; Monkley SJ; Cruz NM; Ong S; Lao DH; Koshman YE; Gu Y; Peterson KL; Chen J; Abel ED; Samarel AM; Critchley DR; Ross RS
J Biol Chem; 2013 Feb; 288(6):4252-64. PubMed ID: 23266827
[TBL] [Abstract][Full Text] [Related]
59. Calcineurin-NFAT signaling regulates the cardiac hypertrophic response in coordination with the MAPKs.
Molkentin JD
Cardiovasc Res; 2004 Aug; 63(3):467-75. PubMed ID: 15276472
[TBL] [Abstract][Full Text] [Related]
60. Upregulation of heat shock transcription factor 1 plays a critical role in adaptive cardiac hypertrophy.
Sakamoto M; Minamino T; Toko H; Kayama Y; Zou Y; Sano M; Takaki E; Aoyagi T; Tojo K; Tajima N; Nakai A; Aburatani H; Komuro I
Circ Res; 2006 Dec; 99(12):1411-8. PubMed ID: 17095722
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
